Article Information
History
- October 7, 2021.
Article Versions
- You are currently viewing Version 1 of this article (October 7, 2021 - 10:13).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jessica Bassi1,*,
- Olivier Giannini2,3,*,
- Chiara Silacci-Fregni1,
- Laura Pertusini4,
- Paolo Hitz2,
- Tatiana Terrot5,
- Yves Franzosi5,
- Francesco Muoio1,
- Christian Saliba1,
- Marcel Meury6,
- Exequiel A. Dellota Jr.6,
- Josh Dillen6,
- Patrick Hernandez6,
- Nadine Czudnochowski6,
- Elisabetta Cameroni1,
- Nicola Beria4,
- Mariangela Ventresca4,
- Alberto Badellino3,
- Soraya Lavorato-Hadjeres4,
- Elisabetta Lecchi3,4,
- Tecla Bonora4,
- Matteo Mattiolo4,
- Guido Trinci3,4,
- Daniela Garzoni4,
- Giuseppe Bonforte4,
- Valentina Forni-Ogna4,
- Davide Giunzioni4,
- Lorenzo Berwert4,
- Ravindra K. Gupta7,8,
- Paolo Ferrari2,4,9,
- Alessandro Ceschi2,5,10,11,
- Pietro Cippà3,4,12,
- Davide Corti1,
- Antonio Lanzavecchia1 and
- Luca Piccoli1,$
- 1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
- 2Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland
- 3Department of Medicine, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland
- 4Division of Nephrology, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland
- 5Clinical Trial Unit, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland
- 6Vir Biotechnology, San Francisco, CA 94158, USA
- 7Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
- 8Department of Medicine, University of Cambridge, Cambridge, UK
- 9Clinical School, University of New South Wales, 2052 Sydney, Australia
- 10Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Science of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland
- 11Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland
- 12Faculty of Medicine, University of Zurich, 8057 Zurich, Switzerland
- ↵$Corresponding author: Luca Piccoli (lpiccoli{at}vir.bio)
↵* These authors contributed equally: Jessica Bassi, Olivier Giannini
Posted October 07, 2021.
Defective neutralizing antibody response to SARS-CoV-2 in vaccinated dialysis patients
